@frguez.bsky.social
Médico especialista en Estomatología. Máster en tabaquismo. Chair of the board of CPE (Cancer Patients Europe) Former ENSP and CNPT president Tenerife-Bruselas
🎙️Don’t miss it!
Webinar “How to Unlock Patient Insights Through Patient Advocacy Group Collaboration”
🗓️ 22 October
🕔 5 PM CEST / 11 AM EST
🔗 Register now: lnkd.in/dUC2M3xT
👉 Learn more: lnkd.in/ddMFDibP
🚨 New Brachytherapy Patient Survey!
CPE would like to hear from cancer patients about their awareness & access to brachytherapy, a targeted radiation treatment that can improve outcomes & reduce side effects.
Your voice matters!
👉 Take the survey: lnkd.in/di7nW5cr
💊 A strong EU biosimilar policy is key to progress in cancer care.
Don't miss our event “Building Equity, Access & Sustainability in Cancer Care with an EU Biosimilar Policy & Strategy”
📍4 Nov 2025, @europarl.europa.eu
⏰09:00-10:30
Registrations: lnkd.in/di6H7kHd
💊 20 years of biosimilars in Europe. Let’s keep building equitable access for all patients.
Don't miss our event at the @europarl.europa.eu:
📍SPINELLI 1G369
🗓️4 November 2025 (9:00-10:30)
🔗Registrations: lnkd.in/di6H7kHd
➡️Learn more: lnkd.in/d4GGyxY8
📢 CPE joined the 6th HTA Stakeholder Network Meeting in Brussels to champion meaningful patient input in JCA.
Together with the European Patients Forum, CPE is co-leading a new project to strengthen patient and caregiver voices in EU HTA.
🔗 Learn more: lnkd.in/diVgKTfa
⌛One week to go!
📢Registrations close on thursday! lnkd.in/di6H7kHd
Join us at the @europarl.europa.eu on 4 November for our event "Building Equity, Access & Sustainability in Cancer Care with an EU Biosimilar Policy & Strategy".
💡Why attend? lnkd.in/dgsRSmp3
📢 CPE at the World Orphan Drug Congress Europe 2025: Advancing patient involvement in JCAs for ATMPs.
CPE highlighted the need for early, structured patient input to ensure faster, fairer access across Europe.
🔗 Read more: lnkd.in/d9-ZbxM3
📢 CPE at the EACR–OECI Virtual Event: Patient Involvement in Cancer Research
Patient involvement is not optional, but essential to delivering better, more equitable cancer research and care.
🔗 Learn more: lnkd.in/g7XqjknM
🎗️October is Breast Cancer Awareness Month 2025
🩷 Together, let’s close the knowledge and access gaps in breast cancer care.
🔗 Learn more about our work on Genomic Testing: lnkd.in/dT39mg_U
🔗 Learn more on our ESR1 & Liquid Biopsy project: lnkd.in/d2ygNAXC
📢 Continuing the Momentum for Pancreatic Cancer Across Europe
👉 Read the full update on progress and next steps: lnkd.in/gE2CePqy
📢 CPE at the PREVENT 4th Plenary Meeting in Gorizia!
CPE remains committed to patient-centred engagement, supporting PREVENT in promoting healthy lifestyles for children across Europe.
🔗 Learn more: lnkd.in/dFprNDcd
🚀 Happening Now at the European Parliament!
Building Equity, Access, and Sustainability in Cancer Care with an EU Biosimilar Policy and Strategy.
🔗 Learn more here: lnkd.in/dgsRSmp3
🏥Los medicamentos biosimilares han ayudado a millones de pacientes a luchar contra el cáncer.
Pero aún debemos garantizar que todos los europeos puedan acceder a tratamientos eficaces y asequibles.
El acceso es la clave.
🗣️ @nicogcasares.bsky.social
🇪🇺 @cancerpatientseu.bsky.social
📢 Advancing Equity and Patient Voice in Cancer Care: Spain’s Response to the EU HTA Regulation
🔗 Read more about the event in our article: lnkd.in/d-XZJreU
🎙️ Don’t miss it!
Registrations are still open for Digestive Cancers Europe's webinar “Patents: Empowering Advocates Through Knowledge”.
🗓️Thursday, 6 November 2025
🕔 4:00–5:30 PM CET
➡️Learn more: lnkd.in/d7M4z2Ur
📢 Bridging Policy and Patient Access: Making the EU HTA Regulation Work for Patients.
CPE & @pce-europe.bsky.social explored explore the impact of the EU HTA Regulation on patient access.
🔗Learn more: lnkd.in/dFTK83eh
📢 Building Equity, Access, and Sustainability in Cancer Care with an EU Biosimilar Policy and Strategy: CPE’s High-Level Policy Event at the European Parliament.
🔗 Learn more: lnkd.in/dpKUummP
#GlobalBiosimilarsWeek 2025 comes to an end!
💡 Biosimilars are reshaping healthcare, improving access, fostering innovation & generating savings for better care.
🔗Read more: lnkd.in/dNegRwWS
➡️Learn more: lnkd.in/dpKUummP
📢 Thank You for Sharing Your Voice!
CPE thanks more than 1,400 cancer patients who answered our survey on combination therapies.
🔗 Read more: lnkd.in/d2ws7uzu
📢 CPE at the Alira Health Webinar: Unlocking Patient Insights Through Meaningful Collaboration
🔗 Learn more: lnkd.in/dSUYFhNq
📢 CPE joined the 1st EP PerMed Expert Symposium in Bilbao!
CPE highlighted how patient advocacy and HTA can turn innovation into real impact.
🔗Read more: lnkd.in/daWrFUNh
📌CPE participated in the European Access Academy (EAA) Fall Convention 2025 in Paris!
CPE is committed to embedding patient voices in Europe’s HTA to drive real impact.
🔗 Read more: lnkd.in/d-byCcSz
👉 Learn more: lnkd.in/diVgKTfa
📌 #SaveTheDate: 7th European Cancer Forum 2025
CPE is proud to support the 7th European Cancer Forum!
📍 Brussels | 🗓️ 4 Dec | 🕛 09:30–14:00 CET
🔗 Registrations: lnkd.in/d8UatNRr
➡️ Read more: lnkd.in/d_x-ASw
📢 CPE at the #EUHPP Live Webinar!
CPE highlighted that patients must be active partners in EU Cancer Mission research to ensure real needs are met and innovation is patient-centred.
➡️ Read more on our full article: lnkd.in/dnf_y6Rj
14 November marks #WorldDiabetesDay.
🩺 Good nutrition is essential for managing diabetes and, as our survey shows, it’s too often overlooked in cancer care.
Thank you to 2,500+ patients, survivors & carers who shared their experiences.
🔗 Learn more: lnkd.in/dEdgbNur
📢 CPE at the EU Life Science Strategy Roundtable in Copenhagen!
CPE continues to push for meaningful patient involvement and tangible impact for all patients.
🔗Learn more: lnkd.in/dgvvYivX
🎗️November is #GastricCancerAwarenessMonth
CPE proudly support @digestivecancerseu.bsky.social in their work to advance equitable access to high-quality cancer care and strengthen the voice of patients across Europe.
🔗 Learn more: lnkd.in/dKHmMEar
